儿童及成人慢性化脓性肺病和支气管扩张临床管理指南

There remain little data on the incidence and prevalence of CSLD/bronchiectasis (NZ incidence in children aged <14-years=3.7/100,000; prevalence in Central Australian Indigenous people: childrenaged <15-years=1470/100,000 based on community data; adults=103/100,00 based on adults were hospitalised). Recently published Australian annual hospitalisation rates for bronchiectasis as a principal diagnosis demonstrate a steady increase between 1998–99 to 2011–12 (14 to 21 per 100,000 population respectively). The increasing trend is a worldwide phenomenon with some countries reporting childhood fatalities,and a growing appreciation of economic cost. Recent data in a Central Australian adult hospitalised cohort reported 34.2% of the cohort died (over ensuing 5-10 years) at a median age of 42.5-years.